CN102727897A - Animal blood anti-coagulant and its application method - Google Patents
Animal blood anti-coagulant and its application method Download PDFInfo
- Publication number
- CN102727897A CN102727897A CN2012102243456A CN201210224345A CN102727897A CN 102727897 A CN102727897 A CN 102727897A CN 2012102243456 A CN2012102243456 A CN 2012102243456A CN 201210224345 A CN201210224345 A CN 201210224345A CN 102727897 A CN102727897 A CN 102727897A
- Authority
- CN
- China
- Prior art keywords
- coagulant
- blood
- animal blood
- value
- application method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention belongs to the field of blood anti-coagulants and specifically relates to an animal blood anti-coagulant and its application method. The anti-coagulant is prepared from the following raw materials of: by weight, 5-10% of trisodium citrate, 20-35% of sodium hexametaphosphate, 5-10% of sodium chloride, 2-8% of citric acid and the balance water. The pH value for preparing the animal blood anti-coagulant is 6.5-7.5. The application method of the anti-coagulant is to uniformly sprinkle the anti-coagulant solution on the surface of prohemocyte with the addition ratio of the anti-coagulant to the prohemocyte being 1:(20-30) (ml/ml). By the adoption of the anti-coagulant provided by the invention, it can be ensured that various components in blood will not or seldom undergo physicochemical reaction and balanced pH value and acid-base value can be achieved, so as to reach the purpose of prolonging shelf life of blood.
Description
Technical field
The invention belongs to a kind of blood anticoagulant, be specifically related to a kind of animal blood anticoagulant agent and method for using.
Background technology
Contain great deal of bioactive substances in the animal blood, be widely used at food, health product, feedstuff, medicine, chemical field.But because the existence of thrombin in the blood, blood is left behind the body get final product self-solidifying in several seconds.Good anticoagulant can not only stop blood coagulation, and range of application is wanted extensively can extend the shelf life.Guarantee the prolongation of blood anticoagulant time, prerequisite is to guarantee that the physics and chemistry variation does not take place or takes place less various compositions in the blood, reach the equilibrium of pH value, PH, and general anticoagulant does not possess this advantage.
Summary of the invention
The object of the present invention is to provide a kind of energy ceramic with antibiotic, easy clean and water activating function.
The present invention also provides above-mentioned method for preparing with energy ceramic of antibiotic, easy clean and water activating function.
Animal blood anticoagulant agent of the present invention is characterized in that, is processed by the raw material of following percetage by weight: trisodium citrate 5 ~ 10%, sodium hexameta phosphate 20 ~ 35%, sodium chloride 5 ~ 10%, citric acid 2 ~ 8%, all the other are water.
Wherein:
The pH value of said animal blood anticoagulant agent is 6.5 ~ 7.5.
The method for using of animal blood anticoagulant agent is: anticoagulant solution evenly is sprayed at former blood surface, with the adding proportion of former blood be 1: (20 ~ 30) (ml/ml).
Compared with prior art, beneficial effect of the present invention is: can guarantee in the blood that various compositions do not take place or physical and chemical reaction takes place less, reach the equilibrium of pH value, PH, thereby reach the purpose that prolongs storage life of blood.
The specific embodiment
Below in conjunction with embodiment the present invention is further described.
Embodiment 1
Animal blood anticoagulant agent of the present invention, the percent meter is processed by 7% trisodium citrate, 35% sodium hexameta phosphate, 6% sodium chloride, 5% citric acid and 47% water by weight, and the pH value of the animal blood anticoagulant agent of processing is 7.
Method for using is: anticoagulant solution evenly is sprayed at former blood surface, with the adding proportion of former blood be 1:25 (ml/ml)..
Embodiment 2
Animal blood anticoagulant agent of the present invention, the percent meter is processed by 5% trisodium citrate, 28% sodium hexameta phosphate, 8% sodium chloride, 2% citric acid and 57% water by weight, and the pH value of the animal blood anticoagulant agent of processing is 6.5.
Method for using is: anticoagulant solution evenly is sprayed at former blood surface, with the adding proportion of former blood be 1:20 (ml/ml).
Embodiment 3
Animal blood anticoagulant agent of the present invention, the percent meter is processed by 9% trisodium citrate, 22% sodium hexameta phosphate, 10% sodium chloride, 6% citric acid and 53% water by weight, and the pH value of the animal blood anticoagulant agent of processing is 6.8.
Method for using is: anticoagulant solution evenly is sprayed at former blood surface, with the adding proportion of former blood be 1:27 (ml/ml).
Embodiment 4
Animal blood anticoagulant agent of the present invention, the percent meter is processed by 6% trisodium citrate, 30% sodium hexameta phosphate, 5% sodium chloride, 8% citric acid and 51% water by weight, and the pH value of the animal blood anticoagulant agent of processing is 7.3.
Method for using is: anticoagulant solution evenly is sprayed at former blood surface, with the adding proportion of former blood be 1:30 (ml/ml).
Claims (3)
1. an animal blood anticoagulant agent is characterized in that, is processed by the raw material of following percetage by weight: trisodium citrate 5 ~ 10%, sodium hexameta phosphate 20 ~ 35%, sodium chloride 5 ~ 10%, citric acid 2 ~ 8%, all the other are water.
2. animal blood anticoagulant agent according to claim 1 is characterized in that, the pH value of said animal blood anticoagulant agent is 6.5 ~ 7.5.
3. the method for using of animal blood anticoagulant agent according to claim 1 is characterized in that, anticoagulant solution evenly is sprayed at former blood surface, with the adding proportion of former blood be 1: (20 ~ 30) (ml/ml).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102243456A CN102727897A (en) | 2012-06-29 | 2012-06-29 | Animal blood anti-coagulant and its application method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102243456A CN102727897A (en) | 2012-06-29 | 2012-06-29 | Animal blood anti-coagulant and its application method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102727897A true CN102727897A (en) | 2012-10-17 |
Family
ID=46984657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102243456A Pending CN102727897A (en) | 2012-06-29 | 2012-06-29 | Animal blood anti-coagulant and its application method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102727897A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105076337A (en) * | 2014-05-20 | 2015-11-25 | 上海杰隆生物制品股份有限公司 | A moving anticoagulant spraying device |
| CN107836701A (en) * | 2017-09-04 | 2018-03-27 | 韩山师范学院 | A kind of pig blood anti-coagulants |
-
2012
- 2012-06-29 CN CN2012102243456A patent/CN102727897A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105076337A (en) * | 2014-05-20 | 2015-11-25 | 上海杰隆生物制品股份有限公司 | A moving anticoagulant spraying device |
| CN107836701A (en) * | 2017-09-04 | 2018-03-27 | 韩山师范学院 | A kind of pig blood anti-coagulants |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013012647A (en) | Fixative solution, for fixation and preservation of biological samples. | |
| ZA202210899B (en) | Solutons for increasing the stability and shelf life of an organ and tissue preservation solution | |
| WO2014188312A3 (en) | Long-term preservation and novel application of chlorous acid aqueous solution formulation | |
| CN102797145B (en) | Nano titanium dioxide-nano silver mixed solution | |
| CN102727897A (en) | Animal blood anti-coagulant and its application method | |
| CN104544463A (en) | Efficient and safe antioxidant | |
| NZ717599A (en) | Compositions and methods for the stability of reactive amino acids in a food matrix | |
| PL2120601T3 (en) | Free-flowing gelatin composition | |
| JP2012220493A5 (en) | ||
| CN102058106A (en) | Composite pig blood anticoagulant and use method thereof | |
| CN105533011A (en) | Ginkgo fruit tea production process | |
| MX364313B (en) | Micronized zeolite suspension, method for preparing same and use thereof as a carrier in agricultural preparations. | |
| CN106387017B (en) | A kind of cold fresh pork nanometer fresh-keeping agent and preparation method thereof and preservation method | |
| CN103444853A (en) | Litchi preservative | |
| CN102150924B (en) | Alliin-containing antistaling agent and production method thereof | |
| CN103250738B (en) | Novel clothing bactericide | |
| CN104886238A (en) | Carica papaya antistaling agent | |
| CN105123915A (en) | Citrus preservative | |
| CN106589474A (en) | Water-soluble chitosan combination agent and application thereof | |
| CN105249137A (en) | Natural fresh-keeping preservative containing natamycin | |
| MX352422B (en) | Self-hardening bioactive cement compositions with partially deacetylated chitin as bone graft substitutes. | |
| CN103120303A (en) | Chrysanthemum processing method | |
| CN104920603A (en) | Preservative for rice preservation | |
| CN104738147A (en) | Novel fresh-keeping agent | |
| CN104738165A (en) | Fresh keeping agent for rice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121017 |